Moravcová J - Search Results

1

Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs.

Lopotová T, Polák J, Schwarz J, Klamová H, Moravcová J. Lopotová T, et al. Among authors: moravcova j. Blood Cells Mol Dis. 2012 Jun 15;49(1):41-7. doi: 10.1016/j.bcmd.2012.04.001. Epub 2012 May 2. Blood Cells Mol Dis. 2012. PMID: 22555024 Clinical Trial.

2

The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR.

Rulcová J, Zmeková V, Zemanová Z, Klamová H, Moravcová J. Rulcová J, et al. Among authors: moravcova j. Leuk Res. 2007 Apr;31(4):483-91. doi: 10.1016/j.leukres.2006.07.021. Epub 2006 Sep 1. Leuk Res. 2007. PMID: 16945414

3

Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.

Klamová H, Marková M, Moravcová J, Sisková M, Cetkovský P, Machová Poláková K. Klamová H, et al. Among authors: moravcova j. Leuk Res. 2009 Nov;33(11):1567-9. doi: 10.1016/j.leukres.2009.05.012. Epub 2009 Jul 5. Leuk Res. 2009. PMID: 19580997

4

Expression patterns of microRNAs associated with CML phases and their disease related targets.

Machová Poláková K, Lopotová T, Klamová H, Burda P, Trněný M, Stopka T, Moravcová J. Machová Poláková K, et al. Among authors: moravcova j. Mol Cancer. 2011 Apr 18;10:41. doi: 10.1186/1476-4598-10-41. Mol Cancer. 2011. PMID: 21501493 Free PMC article.

5

MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?

Lopotová T, Záčková M, Klamová H, Moravcová J. Lopotová T, et al. Among authors: moravcova j. Leuk Res. 2011 Jul;35(7):974-7. doi: 10.1016/j.leukres.2011.03.029. Epub 2011 Apr 20. Leuk Res. 2011. PMID: 21511335

6

Hsp90 - a potential prognostic marker in CML.

Záčková M, Moučková D, Lopotová T, Ondráčková Z, Klamová H, Moravcová J. Záčková M, et al. Among authors: moravcova j. Blood Cells Mol Dis. 2013 Mar;50(3):184-9. doi: 10.1016/j.bcmd.2012.11.002. Epub 2012 Nov 26. Blood Cells Mol Dis. 2013. PMID: 23190580

7

Simplifying procedure for prediction of resistance risk in CML patients - Test of sensitivity to TKI ex vivo.

Žáčková M, Macháčková-Lopotová T, Ondráčková Z, Kuželová K, Klamová H, Moravcová J. Žáčková M, et al. Among authors: moravcova j. Blood Cells Mol Dis. 2016 May;58:67-75. doi: 10.1016/j.bcmd.2016.03.005. Epub 2016 Mar 10. Blood Cells Mol Dis. 2016. PMID: 27067491

8

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.

Moravcová J, Zmeková V, Klamová H, Voglová J, Faber E, Michalová K, Rabasová J, Jarosová M. Moravcová J, et al. Leuk Res. 2004 Apr;28(4):415-9. doi: 10.1016/j.leukres.2003.08.002. Leuk Res. 2004. PMID: 15109543

9

Gene expression profiles of two accelerations in a CML patient.

Fiser K, Klamová H, Moravcová J. Fiser K, et al. Among authors: moravcova j. Leuk Res. 2006 Jun;30(6):751-3. doi: 10.1016/j.leukres.2005.10.008. Epub 2005 Nov 14. Leuk Res. 2006. PMID: 16289682 No abstract available.

10

Complex chromosomal rearrangements in patients with chronic myeloid leukemia.

Babicka L, Zemanova Z, Pavlistova L, Brezinova J, Ransdorfova S, Houskova L, Moravcova J, Klamova H, Michalova K. Babicka L, et al. Among authors: moravcova j. Cancer Genet Cytogenet. 2006 Jul 1;168(1):22-9. doi: 10.1016/j.cancergencyto.2005.11.017. Cancer Genet Cytogenet. 2006. PMID: 16772117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters